Interest in ESG bonds has been steadily growing but what exactly are they and why are they being bought and sold?
This content was published on
1 minute
I work as a designer in the multimedia team at SWI swissinfo.ch. At the intersection between journalism, design and marketing, I develop infographics, animations, maps and new formats for social media.
I am an experienced video journalist passionate about making complex topics accessible and engaging through compelling multimedia storytelling. Focused on social and environmental issues, I produce various video formats on a wide range of topics, specialising in impactful explainer videos with motion graphics and stop-motion animation.
During my studies in cinema, English literature and journalism, I’ve gained experience in radio, television, and print across Switzerland. After working with the Locarno Film Festival’s image & sound team, I joined SWI swissinfo.ch in 2018 to produce local and international reportages.
I report on the Swiss pharmaceutical industry and healthcare topics such as access to medicine, biomedical innovation, and the impact of diseases like cancer.
I grew up just outside San Francisco and studied international affairs with a focus on development economics and healthcare policy. Prior to joining SWI swissinfo.ch in 2018, I was a freelance journalist and a researcher on business and human rights.
Since the European Investment Bank issued the first ESG bond in 2007, many companies and businesses have followed suit by producing their own.
The term ESG bonds stands for Environmental, Social and Governance bonds. They are categorised as green, social, sustainability and sustainability-linked depending on their end goal. The first three are loans to fund specific projects, the latter are used to attain a company’s sustainability targets.
Today, ESG bonds account for 10% of all bonds worldwide but they’re attracting a vast and diverse base of investors and companies. ESG bonds are contributing to the achievement of global climate and social goals, but clear guidelines to gauge their credibility and impact do not as yet exist.
More
More
Can Novartis’s sustainability-linked bond make good on its promises?
This content was published on
Novartis’s sustainability-linked bond was a world first for the pharmaceutical industry. But will it improve access to medicine?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.